Ozempic is displayed in a pharmacy in Provo

A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo

Post navigation

Previous: Eli Lilly is still seeking UK approval on pen for weight-loss drug

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Sign up for our free Bull Bear Daily Newsletter!

Discover new market trends and ideas directly to your inbox.

By providing your email, you agreed to receive informational and promotional messages from us. You may opt out at any time by clicking the unsubscribe at the bottom of each email. See our Privacy Policy for more information.

Search